Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-239989
Filing Date
2023-09-22
Accepted
2023-09-22 06:06:57
Documents
2
Period of Report
2023-09-22

Document Format Files

Seq Description Document Type Size
1 6-K d552397d6k.htm 6-K 9465
2 EX-99.1 d552397dex991.htm EX-99.1 50041
  Complete submission text file 0001193125-23-239989.txt   60682
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 231270198
SIC: 2834 Pharmaceutical Preparations